UPDATE : Tuesday, July 23, 2019
상단여백
HOME Special Special Series in Celebration of KBR’s 2nd Anniversary Pharma in Battle
[Special] Interleukin inhibitors Cosentyx, Taltz target psoriasis market[Pharma in Battle ②]  IL-17A inhibitor: Novartis’ Cosentyx vs. Lilly’s Taltz
  • Kim Yun-mi
  • 승인 2019.03.26 14:56
  • 댓글 0
Comments 0
Please leave the first comment.
여백
여백
여백
Back to Top